2026 executive update · proposed pandemic agreement · Leadership action
Governments Agree to Continue Steady Progress on Proposed Pandemic Agreement
When governments agreed in May 2024 to continue work on a proposed pandemic agreement, the unresolved issues were already operationally familiar to healthcare executives: pathogen information, equitable access to vaccines…
At a Glance
As of August 2026, that annex is not final. WHO Member States concluded a seventh negotiating session in July and scheduled an eighth for September. The agreement is therefore an important policy architecture, but leaders should distinguish adoption from implementation. WHO states that the instrument can…
Executive perspective
When governments agreed in May 2024 to continue work on a proposed pandemic agreement, the unresolved issues were already operationally familiar to healthcare executives: pathogen information, equitable access to vaccines and treatments, prevention, One Health coordination, financing, and the capacity of health systems to respond. The negotiations later advanced substantially. The World Health Assembly adopted the WHO Pandemic Agreement in May 2025, while work continued on the Pathogen Access and Benefit Sharing, or PABS, annex.
As of August 2026, that annex is not final. WHO Member States concluded a seventh negotiating session in July and scheduled an eighth for September. The agreement is therefore an important policy architecture, but leaders should distinguish adoption from implementation. WHO states that the instrument can move toward signature and ratification after the PABS annex is adopted, and it will enter into force after 60 ratifications.
For hospitals and health systems, the practical lesson is neither to predict every legal outcome nor to wait. A pandemic agreement cannot substitute for local readiness, and local readiness cannot solve cross-border inequity. Executives can use the emerging framework as a stress test for surveillance, supplies, workforce, research, data sharing, continuity, and trust. The objective is an operating system that protects care through uncertainty while remaining aligned with public authorities.
Leadership priorities
Build an integrated leadership response
Translate Global Commitments Into Enterprise Decisions
Assign one executive group to track the WHO Pandemic Agreement, the PABS negotiations, International Health Regulations, and relevant national requirements. Its role is not international diplomacy. It is to identify which developments could change procurement, laboratory practices, research participation, reporting, emergency operations, or access to countermeasures. Maintain a short assumptions log that distinguishes adopted text, unfinished provisions, domestic obligations, and voluntary preparation.
Map each external commitment to an internal decision owner. Pathogen sharing may affect laboratories and research; equitable product access may affect pharmacy and supply chain; prevention may affect infection control and community partnerships; health-system resilience may affect facilities, finance, and workforce. Legal and compliance leaders should interpret obligations, while operators define how readiness would be demonstrated.
Brief the board on material exposure rather than negotiating detail. Show critical dependencies, known gaps, funding decisions, and readiness evidence. Avoid claiming that WHO can direct local clinical operations or impose domestic measures. The agreement itself preserves national sovereignty. Clear distinctions protect credibility and help leaders focus on the capabilities they actually control.
Build a Readiness Baseline Around Essential Services
Start with the services that must continue during a prolonged emergency: emergency care, intensive care, maternal care, dialysis, pharmacy, laboratory, oxygen, communications, food, utilities, supply distribution, and revenue-cycle functions needed to sustain operations. Define minimum safe capacity, acceptable degradation, recovery time, staffing dependencies, and the conditions that require regional coordination.
Test assumptions across multiple threats. A respiratory pathogen may drive isolation and ventilation needs; another hazard may stress laboratories, blood products, therapeutics, or staff availability differently. Use scenario ranges rather than a single forecast. Include simultaneous cyber disruption, supply interruption, misinformation, or severe weather because compound events expose dependencies hidden in ordinary drills.
Reconcile emergency plans with day-to-day capacity management. A plan that requires beds, personnel, negative-pressure rooms, or inventory that do not exist at baseline is not ready. Document trigger levels for conservation, cohorting, service changes, mutual aid, and crisis standards under applicable authority. Ensure ethical and clinical review before an emergency, with transparent escalation and documentation.
Account for variation across jurisdictions and facilities. A multistate system may face different public-health orders, licensure rules, reporting channels, emergency authorities, and community resources at the same time. Maintain a local annex to the enterprise playbook, with named legal and operational contacts. Central command should set common principles and share scarce expertise while allowing documented local decisions. This balance reduces delay without pretending that one policy can answer every community's conditions.
Secure Countermeasure and Supply Access Before Demand Peaks
Map tier-one and tier-two dependencies for essential medicines, diagnostics, personal protective equipment, oxygen, devices, raw materials, logistics, and cold chain. Identify single-source products, geographic concentration, substitute constraints, expiration risk, and the data needed to allocate scarce supplies. Contract language should address visibility, notification, allocation, cybersecurity, and continuity, not only unit price.
Build relationships with public health agencies, coalitions, distributors, manufacturers, laboratories, and neighboring providers before an event. Clarify how requests, allocation decisions, product recalls, emergency-use information, and inventory signals will move. Smaller and rural organizations need an explicit place in regional planning so scarce products do not flow only to buyers with the greatest purchasing leverage.
Use equitable-access principles as operating criteria. Develop allocation processes based on clinical need and public-health risk, with review for geographic, disability, language, and socioeconomic barriers. Track whether eligible people can reach testing, vaccination, and treatment. A countermeasure sitting in inventory is not access; access requires trusted communication, convenient delivery, safe administration, follow-up, and understandable appeals.
Make Data, Research, and Trust Part of Preparedness
Define the minimum surveillance and operational data set before the next emergency. Include laboratory signals, syndromic trends, bed and staffing capacity, mortality, supplies, vaccination, treatment, and outcomes by meaningful population characteristics. Establish definitions, reporting cadence, provenance, quality checks, privacy safeguards, and accountable recipients. Automate where practical, but retain a process for rapid validation when conditions change.
Prepare research pathways in advance. Template agreements, consent approaches, data-use terms, biospecimen governance, pharmacy processes, and institutional review board surge procedures can reduce delay without weakening oversight. Community representation should shape priorities and communications, especially when research burdens and benefits may be uneven. Participation must remain voluntary and understandable.
Trust is an operational asset. Design a coordinated communication structure with clinical experts, public health, community organizations, and interpreters. Publish what is known, unknown, changing, and locally actionable. Monitor questions and misinformation without treating disagreement as misconduct. Leaders should explain why recommendations change when evidence changes. Consistency, humility, and visible correction are stronger than false certainty.
Finance, Exercise, and Improve the Readiness System
Create a multiyear preparedness portfolio that separates baseline resilience from surge expense. Baseline investment may include ventilation, laboratories, cybersecurity, cross-training, analytics, inventory visibility, communications, and community partnerships. Surge plans should identify emergency labor, alternate care, transportation, testing, security, and supply costs. Record potential reimbursement sources without assuming they will arrive quickly or cover every expense.
Exercise the system from executive decision to bedside execution. Use short functional drills for notification, incident command, downtime, product allocation, and public communication, then conduct a broader regional exercise. Include nights, weekends, ambulatory sites, post-acute partners, behavioral health, and vendors. Evaluate how decisions affect patient flow and routine care, not only whether participants completed a checklist.
Close every exercise and real event with assigned corrective actions, funding, due dates, and retesting. Track recurring failures such as unclear authority, inaccessible contact lists, inconsistent data, or unworkable staffing assumptions. Preparedness maturity is demonstrated when evidence changes budgets and operating design. A binder updated annually is documentation; a tested learning cycle is resilience.
Coordinate the financial model with insurers, emergency-management agencies, healthcare coalitions, and key suppliers. Clarify which costs require prior documentation, what evidence supports emergency claims, and how cash will move if normal billing or payment channels slow. Establish an executive threshold for emergency liquidity and rehearse the approval process. Financial endurance protects the clinical mission when a response lasts longer than the initial surge of public attention and temporary support.
Leadership cadence
Start, strengthen, and measure the system in 90 days.
Phase 1, days 1 to 30
Establish executive ownership, summarize the current agreement and PABS status, and map external developments to internal functions. Identify essential services and complete a rapid dependency review covering workforce, data, laboratory, suppliers, utilities, technology, community partners, and public-health coordination.
Phase 2, days 31 to 60
Select two high-consequence gaps and fund corrective work. Update triggers, minimum service levels, allocation principles, data definitions, and partner contacts. Tabletop a compound scenario that combines an infectious threat with a cyber or supply disruption, and document decisions that lacked authority or usable information.
Phase 3, days 61 to 90
Test the corrected workflows during representative shifts, validate communications with community partners, and retest one failed dependency. Present the board with residual risk, investment choices, equity indicators, and a 12-month exercise calendar. Assign one owner and completion date to every remaining corrective action.
Decision-grade measurement
Decision-Grade Metrics
- Essential services with validated minimum capacity, recovery targets, and current continuity procedures
- Critical supplies with tier-two visibility, alternatives, allocation rules, and tested replenishment plans
- Time to activate incident command, validate a signal, notify partners, and make a documented decision
- Staff available by critical role, cross-training coverage, absence assumptions, and fatigue indicators
- Laboratory, bed, workforce, inventory, and outcome data completeness, latency, and reconciliation error
- Countermeasure access and uptake by geography, language, disability, risk, and community
- Exercises completed, high-risk findings closed, repeat failures, and corrective actions retested
- Baseline preparedness spending, unfunded exposure, emergency liquidity, and verified reimbursement
SEO
SEO title: Proposed Pandemic Agreement: 2026 Executive Readiness Guide
Meta description: What the proposed pandemic agreement became, what remains unfinished, and how healthcare executives can strengthen readiness, equity, and resilience.
Focus keyphrase: proposed pandemic agreement
Conclusion
Turn strategy into an accountable operating system.
The pandemic agreement process moved from unfinished negotiations in May 2024 to adoption in May 2025, while the PABS annex remained under negotiation in August 2026. That sequence matters, but it does not change the executive obligation to maintain safe, coordinated, and equitable readiness now.
Health systems should use the global framework as a disciplined prompt: protect essential services, understand dependencies, strengthen data and research pathways, secure access to countermeasures, communicate honestly, and test the system. Preparedness becomes credible when leaders can show not only a plan, but evidence that people, partners, and processes can perform under pressure.
Executive questions
Frequently Asked Questions
1. Was the WHO Pandemic Agreement adopted?
Yes. The World Health Assembly adopted it in May 2025. However, work on the PABS annex continued as of August 2026, and additional steps are required before the agreement opens for signature and ratification and ultimately enters into force.
2. Does the agreement allow WHO to direct U.S. hospitals?
No. The adopted text states that it does not give the WHO Secretariat authority to direct national or domestic laws or mandate measures such as lockdowns or vaccination requirements. Health systems should follow applicable governmental authority and verified guidance.
3. What is the PABS system?
PABS refers to Pathogen Access and Benefit Sharing. Its intended purpose is to support rapid, accountable access to pathogens with pandemic potential and fair sharing of benefits arising from their use, including vaccines, diagnostics, and therapeutics. The annex details remained under negotiation.
4. Why should hospital boards monitor an international agreement?
The agreement addresses capabilities that affect enterprise risk, including prevention, surveillance, research, supply access, workforce, financing, and health-system resilience. Boards do not need negotiating detail, but they should understand dependencies, gaps, investment choices, and management's readiness evidence.
5. What is the most useful preparedness exercise for an executive team?
Use a scenario that forces tradeoffs across care capacity, scarce products, workforce, data uncertainty, public communication, and partner coordination. Require real decision owners to act with current tools and contact lists, then fund and retest the highest-consequence failures.




